Article
Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause severe disease
2022-03-07
Abstract excerpt
Pan-betacoronavirus neutralizing antibodies may hold the key to developing broadly protective vaccines against coronaviruses that cause severe disease, for anticipating novel pandemic-causing viruses, and to respond more effectively to SARS-CoV-2 variants. The emergence of the Omicron variant of SARS-CoV-2 has illustrated the limitations of solely targeting the receptor binding domain (RBD) of the envelope Spike (...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c8f75017-0fd5-5023-b106-3450b6b38618
- DOI
- 10.1101/2022.03.04.479488
